Wockhardt Limited (WOCKPHARMA) Share Price & AI Investment Analysis

Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH zidebactam/cefepime, a novel beta lactam enhancer mechanism for the treatment of sepsis and hospital/ventilator associated pneumonia; FOVISCU, an antibiotic for gram-negative infections; MIQNAF nafithromycin, which targets azithromycin-resistant comm. Track Wockhardt Limited's live NSE:WOCKPHARMA share price ₹2,185.40 (-0.08%), market cap ₹₹355B, P/E 86.9. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for WOCKPHARMA — real-time NSE India stock intelligence.